CNC
BIIB icon

Citizens & Northern Corp’s Biogen BIIB Stock Holding History

Citizens & Northern Corp’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Sell
6,943
-194
-3% -$37.1K 0.34% 55
2026
Q1 		$1.31M Buy
7,137
+225
+3% +$41.5K 0.33% 61
2025
Q4 		$1.22M Sell
6,912
-84
-1% -$13.7K 0.3% 67
2025
Q3 		$980K Sell
6,996
-32
-0.5% -$4.33K 0.24% 78
2025
Q2 		$883K Buy
7,028
+2,315
+49% +$288K 0.24% 81
2025
Q1 		$645K Buy
4,713
+1,819
+63% +$260K 0.18% 89
2024
Q4 		$443K Sell
2,894
-1,328
-31% -$224K 0.12% 99
2024
Q3 		$818K Sell
4,222
-130
-3% -$27.2K 0.25% 80
2024
Q2 		$1.01M Sell
4,352
-149
-3% -$32.4K 0.32% 77
2024
Q1 		$971K Buy
4,501
+97
+2% +$22.7K 0.33% 75
2023
Q4 		$1.14M Sell
4,404
-190
-4% -$46.7K 0.41% 60
2023
Q3 		$1.18M Sell
4,594
-131
-3% -$35K 0.47% 57
2023
Q2 		$1.35M Sell
4,725
-160
-3% -$47.6K 0.51% 53
2023
Q1 		$1.36M Buy
4,885
+24
+0.5% +$6.64K 0.53% 52
2022
Q4 		$1.35M Buy
4,861
+180
+4% +$50.8K 0.56% 50
2022
Q3 		$1.25M Buy
4,681
+7
+0.1% +$1.49K 0.59% 46
2022
Q2 		$953K Buy
+4,674
New +$955K 0.42% 59
2020
Q1 		– Sell
-2,713
Closed -$805K – 96
2019
Q4 		$805K Sell
2,713
-202
-7% -$56K 0.4% 61
2019
Q3 		$679K Sell
2,915
-75
-3% -$17.5K 0.37% 65
2019
Q2 		$699K Sell
2,990
-102
-3% -$23.6K 0.39% 65
2019
Q1 		$731K Sell
3,092
-170
-5% -$53.5K 0.41% 68
2018
Q4 		$982K Buy
3,262
+14
+0.4% +$4.47K 0.68% 51
2018
Q3 		$1.15M Sell
3,248
-1,348
-29% -$464K 0.78% 53
2018
Q2 		$1.33M Buy
4,596
+47
+1% +$13.2K 0.95% 46
2018
Q1 		$1.25M Sell
4,549
-56
-1% -$17.4K 0.93% 49
2017
Q4 		$1.47M Sell
4,605
-739
-14% -$237K 1.04% 42
2017
Q3 		$1.67M Sell
5,344
-244
-4% -$72.3K 1.27% 27
2017
Q2 		$1.52M Sell
5,588
-102
-2% -$27K 1.19% 30
2017
Q1 		$1.56M Buy
5,690
+120
+2% +$33.9K 1.25% 31
2016
Q4 		$1.58M Buy
5,570
+107
+2% +$31.7K 1.19% 26
2016
Q3 		$1.71M Sell
5,463
-78
-1% -$23.1K 1.34% 19
2016
Q2 		$1.34M Buy
5,541
+150
+3% +$39.5K 1.05% 36
2016
Q1 		$1.4M Buy
5,391
+1,770
+49% +$468K 1.11% 32
2015
Q4 		$1.11M Buy
3,621
+1,390
+62% +$399K 0.9% 37
2015
Q3 		$651K Buy
+2,231
New +$737K 0.51% 73

Other funds holding BIIB

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Citizens & Northern Corp's BIIB Position: Q2 2026 in Review

Citizens & Northern Corp reduced its Biogen (BIIB) stake by 2.7% in Q2 2026, selling an estimated $37.1K and leaving 6,943 shares worth $1.5M. The position accounts for 0.34% of the portfolio, ranked #55.

Citizens & Northern Corp first reported a position in BIIB in Q3 2015 and has held it in 35 quarters since. The position peaked at $1.71M in Q3 2016. 164 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Citizens & Northern Corp held 6,943 shares of Biogen worth $1.5M as of Q2 2026.
  • Citizens & Northern Corp sold 194 Biogen shares in Q2 2026, an estimated $37.1K.
  • Biogen made up 0.34% of Citizens & Northern Corp's portfolio in Q2 2026, its #55 holding.
  • Citizens & Northern Corp first reported a position in Biogen in Q3 2015 and has held it in 35 quarters since.
  • Citizens & Northern Corp's Biogen position peaked at $1.71M in Q3 2016.
  • 164 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Citizens & Northern Corp's 13F filing for Q2 2026, filed 17 Jul 2026.